Ranbaxy Laboratories has reportedly received US Food and Drug Administration (US FDA) approval for a particular drug called Plendil generic. The drug is used for hypertension. The company was expected to be the authorised generic for this particular drug, but it is already genericised and there are already 6-7 players in this market for this particular drug.
Epic Research
Wednesday, December 18, 2013
Epic Update : Ranbaxy Laboratories
Labels:
Best Stock Tips,
Best Tips For Intraday,
Bullion Tips,
Commodity Tips,
equity tips,
Equity Tips Free Trial,
Forex Tips,
Forex Tips MCX Tips,
Free Trial,
MCX Tips,
NCDEX Tips,
NCDEX Tips.,
Penny Stock Tips,
share market,
share tips,
share tips india,
stock tips,
stock tips india,
Stock Trading Tips.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment